FDA drug approval process

By Heather Mack March 20, 2017
New York-based healthcare technology company, Aetion, which makes an analytics platform to assess real-world evidence from a range of sources, has raised $11.2 million in Series A funding. Flare Capital Partners, a VC firm focused on early stage health technology and services, led the round, and Lakestar also contributed. Aetion’s Evidence Platform, which the company launched in 2015, allows...